ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $134 | -99.7% | 6,163 | +207.7% | 0.00% | – |
| Q3 2022 | $39,000 | +129.4% | 2,003 | +131.6% | 0.00% | – |
| Q2 2022 | $17,000 | -79.8% | 865 | -69.3% | 0.00% | – |
| Q1 2022 | $84,000 | -91.2% | 2,817 | -93.1% | 0.00% | – |
| Q4 2021 | $954,000 | +339.6% | 40,960 | +488.8% | 0.00% | – |
| Q3 2021 | $217,000 | +161.4% | 6,957 | +195.0% | 0.00% | – |
| Q2 2021 | $83,000 | -87.0% | 2,358 | -87.0% | 0.00% | – |
| Q1 2021 | $637,000 | +81.0% | 18,070 | +92.7% | 0.00% | – |
| Q4 2020 | $352,000 | +5.4% | 9,377 | -6.4% | 0.00% | – |
| Q3 2020 | $334,000 | +71.3% | 10,015 | +36.9% | 0.00% | – |
| Q2 2020 | $195,000 | +186.8% | 7,316 | +75.6% | 0.00% | – |
| Q1 2020 | $68,000 | -75.5% | 4,166 | -61.7% | 0.00% | – |
| Q4 2019 | $277,000 | +158.9% | 10,885 | +102.9% | 0.00% | – |
| Q3 2019 | $107,000 | -50.2% | 5,364 | -19.4% | 0.00% | – |
| Q2 2019 | $215,000 | +150.0% | 6,658 | +148.8% | 0.00% | – |
| Q1 2019 | $86,000 | +2050.0% | 2,676 | +1649.0% | 0.00% | – |
| Q4 2018 | $4,000 | -96.6% | 153 | -95.7% | 0.00% | – |
| Q3 2018 | $117,000 | +408.7% | 3,528 | +428.9% | 0.00% | – |
| Q2 2018 | $23,000 | -88.0% | 667 | -88.7% | 0.00% | – |
| Q1 2018 | $192,000 | +11.6% | 5,893 | -12.0% | 0.00% | – |
| Q4 2017 | $172,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |